Deutsche Bank Ag\ Mesoblast LTD Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.38 - $10.63 $5,712 - $17,964	-1,690 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.74 - $7.42 $7,031 - $9,089	-1,225 Reduced 42.02%	1,690 $12,000
Q3 2019 Nov 14, 2019	SELL	$4.68 - $7.42 $21,195 - $33,605	-4,529 Reduced 60.84%	2,915 $20,000
Q2 2019 Aug 14, 2019	SELL	$4.67 - $5.88 $209,524 - $263,812	-44,866 Reduced 85.77%	7,444 $39,000
Q1 2019 May 15, 2019	BUY	$4.19 - $5.25 $146,122 - $183,088	34,874 Added 200.01%	52,310 $274,000
Q4 2018 Feb 14, 2019	SELL	$3.51 - $8.6 $360,828 - $884,080	-102,800 Reduced 85.5%	17,436 $71,000
Q3 2018 Nov 14, 2018	BUY	$5.75 - $8.16 $422,199 - $599,156	73,426 Added 156.86%	120,236 $981,000
Q2 2018 Aug 14, 2018	SELL	$5.27 - $6.21 $162,869 - $191,920	-30,905 Reduced 39.77%	46,810 $257,000
Q1 2018 May 15, 2018	BUY	$4.91 - $7.72 $207,771 - $326,679	42,316 Added 119.54%	77,715 $449,000
Q4 2017 Feb 14, 2018	SELL	$4.91 - $7.23 $59,479 - $87,584	-12,114 Reduced 25.5%	35,399 $206,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $7.41 $256,570 - $352,071	47,513	47,513 $260,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.